Page last updated: 2024-09-04

vatalanib and tipifarnib

vatalanib has been researched along with tipifarnib in 2 studies

Compound Research Comparison

Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010)
(vatalanib)
Studies
(tipifarnib)
Trials
(tipifarnib)
Recent Studies (post-2010) (tipifarnib)
27642983099294

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)tipifarnib (IC50)
Chain B, Protein farnesyltransferase beta subunitRattus norvegicus (Norway rat)0.0007
Cytochrome P450 3A4Homo sapiens (human)2.88
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaBos taurus (cattle)0.5503
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)2.2237
Protein farnesyltransferase subunit betaBos taurus (cattle)0.0006
Protein farnesyltransferase subunit betaHomo sapiens (human)0.0019
Geranylgeranyl transferase type-1 subunit betaHomo sapiens (human)10
Geranylgeranyl transferase type-1 subunit betaBos taurus (cattle)1.1
Protein farnesyltransferase alpha subunitPlasmodium falciparum (malaria parasite P. falciparum)0.017
CAAX farnesyltransferase subunit beta Plasmodium falciparum (malaria parasite P. falciparum)0.017

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borner, MM1
Filov, VA; Gershanovich, ML; Imianitov, EN; Stukov, AN1

Reviews

2 review(s) available for vatalanib and tipifarnib

ArticleYear
[Molecular targets in colon cancer].
    Therapeutische Umschau. Revue therapeutique, 2006, Volume: 63, Issue:4

    Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Camptothecin; Cetuximab; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Drug Delivery Systems; ErbB Receptors; Gefitinib; Humans; Imatinib Mesylate; Indoles; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Quinolones; Receptors, Platelet-Derived Growth Factor; Receptors, Somatomedin; Signal Transduction; Sirolimus; Sunitinib

2006
[Problems in the current target therapy of malignancies].
    Voprosy onkologii, 2005, Volume: 51, Issue:5

    Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Azathioprine; Benzamides; Bevacizumab; Cetuximab; Erlotinib Hydrochloride; Gefitinib; Humans; Imatinib Mesylate; Neoplasms; Phthalazines; Piperazines; Pyridines; Pyrimidines; Quinazolines; Quinolones; Rituximab; Sesquiterpenes; Sesquiterpenes, Guaiane; Trastuzumab

2005